These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR. Zusterzeel R; Curtis JP; Caños DA; Sanders WE; Selzman KA; Piña IL; Spatz ES; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Strauss DG J Am Coll Cardiol; 2014 Sep; 64(9):887-94. PubMed ID: 25169173 [TBL] [Abstract][Full Text] [Related]
49. [Comment on "Defining left bundle branch block in the era of cardiac resynchronization therapy"]. Oliveira M Rev Port Cardiol; 2011 Oct; 30(10):809-11. PubMed ID: 22118135 [TBL] [Abstract][Full Text] [Related]
50. Transseptal conduction as an important determinant for cardiac resynchronization therapy, as revealed by extensive electrical mapping in the dyssynchronous canine heart. Strik M; van Deursen CJ; van Middendorp LB; van Hunnik A; Kuiper M; Auricchio A; Prinzen FW Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):682-9. PubMed ID: 23873141 [TBL] [Abstract][Full Text] [Related]
52. Electrocardiographic criteria of true left bundle branch block: a simple sign to predict a better clinical and instrumental response to CRT. Mascioli G; Padeletti L; Sassone B; Zecchin M; Lucca E; Sacchi S; Boggian G; Tondo AL; Belvito C; Bakhtadze N; Borrelli A; Sinagra G Pacing Clin Electrophysiol; 2012 Aug; 35(8):927-34. PubMed ID: 22651702 [TBL] [Abstract][Full Text] [Related]
53. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Goldenberg I; Hall WJ; Beck CA; Moss AJ; Barsheshet A; McNitt S; Polonsky S; Brown MW; Zareba W J Am Coll Cardiol; 2011 Aug; 58(7):729-37. PubMed ID: 21816309 [TBL] [Abstract][Full Text] [Related]
54. The ECG in cardiac resynchronization therapy: influence of left and right ventricular preactivation and relation to acute response. Bogaard MD; Hesselink T; Meine M; Loh P; Hauer RN; Cramer MJ; Doevendans PA; Tuinenburg AE J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1237-45. PubMed ID: 22734629 [TBL] [Abstract][Full Text] [Related]
55. Acceleration-dependent left bundle branch block with severe left ventricular dyssynchrony results in acute heart failure: are there more patients who benefit from cardiac resynchronization therapy? Zeppenfeld K; Schalij MJ; Bleeker GB; Holman ER; Bax JJ J Cardiovasc Electrophysiol; 2006 Jan; 17(1):101-3. PubMed ID: 16426411 [TBL] [Abstract][Full Text] [Related]
56. Underestimation of duration of ventricular activation by 12-lead ECG compared with direct measurement of activation duration derived from implanted pacemaker leads. Duncan AM; Lim E; Mebrate Y; Wong T; Gibson DG Int J Cardiol; 2011 Oct; 152(1):35-42. PubMed ID: 20678820 [TBL] [Abstract][Full Text] [Related]
57. Reliability and reproducibility of QRS duration in the selection of candidates for cardiac resynchronization therapy. De Guillebon M; Thambo JB; Ploux S; Deplagne A; Sacher F; Jais P; Haissaguerre M; Ritter P; Clementy J; Bordachar P J Cardiovasc Electrophysiol; 2010 Aug; 21(8):890-2. PubMed ID: 20233266 [TBL] [Abstract][Full Text] [Related]
59. The value of the 12-lead ECG for evaluation and optimization of cardiac resynchronization therapy in daily clinical practice. van Deursen CJ; Blaauw Y; Witjens MI; Debie L; Wecke L; Crijns HJ; Prinzen FW; Vernooy K J Electrocardiol; 2014; 47(2):202-11. PubMed ID: 24444866 [TBL] [Abstract][Full Text] [Related]
60. QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy. Kandala J; Upadhyay GA; Altman RK; Parks KA; Orencole M; Mela T; Kevin Heist E; Singh JP Eur Heart J; 2013 Aug; 34(29):2252-62. PubMed ID: 23571836 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]